Lori McLean Chief Executive Officer

With more than twenty years of successful business leadership, Lori brings her managerial and technical focus to bear on Polyglot’s mission: To improve medication adherence and healthcare literacy for high-risk patients. In the development of industry-leading products for hospitals, pharmacies and health care systems, Polyglot is dedicated to effective patient communication and reducing the high financial and human tolls of low health literacy in its many forms.

In her previous role as Polyglot’s Chief Operating Officer, Lori drove the company’s business and sales strategy, maximizing the benefit of Meducation to healthcare providers, pharmacies and their patients.

Before joining Polyglot, Lori’s managerial focus was on international, high-tech business development and sales. Her track record of successfully driving growth and peak performance spans both mature and start-up environments. At telecoms leader, Avaya, Lori led global Cloud Solution Sales and Strategy. Over a lengthy career at Nortel Networks, Lori served as General Manager of Alliances, VP Canada Region and VP Americas Region Marketing. In France, Lori guided MNC, a French telecoms joint venture, from start-up to profit in less than three years.

With a background in engineering and finance, Lori holds a Bachelor of Applied Science, Electrical Engineering, from the University of British Columbia.


Sims Preston President and Chairman of the Board

R.J. Sims Preston, is an experienced attorney with an extensive background in the technology space. Prior to joining Polyglot, Sims spent fourteen years as a lawyer, both in private practice and as in-house counsel for some of the world’s most dynamic and innovative companies.

  • Increased Meducation revenue 8-fold from 2011–2015
  • 15+ years’ experience in private practice and as senior in-house counsel for global technology and pharmaceutical firms
  • Extensive intellectual property, software licensing, transactional, M&A, and litigation experience
  • JD, Cum Laude, Duke University School of Law

Dan Fritsch, PhD Chief Technology Officer

Dan Fritsch has over 20 years of experience in software systems architecture and database design. Dr. Fritsch holds a BS from The Johns Hopkins University and a PhD from the University of North Carolina (UNC) at Chapel Hill in biomedical engineering. Upon graduating from UNC, he was awarded a fellowship from the National Cancer Institute and performed research in image-based radiotherapy treatment verification, which led to his dual appointment as professor of biomedical engineering and radiation oncology. While at UNC, Dan taught graduate-level coursed in object oriented programming and database systems theory in the joint Medical Informatics program at UNC and Duke. Dr. Fritsch has held CTO roles at several early-stage software companies and joined Polyglot in 2008.

  • Assistant professor of Biomedical Engineering and Radiation Oncology, UNC Chapel Hill
  • Instructor in Joint Program in Medical Informatics at Duke and UNC
  • Fellow, National Cancer Institute, Department of Radiation Oncology at UNC
  • PhD in Biomedical Engineering, UNC
  • Bachelor of Science Biomedical Engineering, Johns Hopkins University

Charles Lee, MD President & Founder

Charles Lee has been a leading national advocate for simplifying and making medical information more understandable for patients. Dr. Lee is founder and president of Polyglot, built with a mission to develop practical, affordable multi-language technology solutions to improve healthcare access and reduce disparities for underserved and limited English proficient patient populations. He is an internal medicine physician and past NLM fellow in medical informatics at UNC Chapel Hill/Duke University. He has extensive experience in patient-centered healthcare communication, language barriers, health literacy, healthcare software user experience (UX), and instructional design. Dr. Lee is a past recipient of the Tibbetts Award from the U.S. Small Business Administration for his work in healthcare and technology and the Health Care Heroes award from the Triangle Business Journal (Raleigh, NC). He is currently also adjunct assistant professor at the UNC Eshelman School of Pharmacy where he is working on several projects to improve medication adherence. Dr. Lee is Co-Chair of the Sullivan Institute for Healthcare Innovations’s Care Coordination Workgroup, a member of the FDA's Risk Communication Advisory Committee and the Duke Clinical Research Institutes’ Medication Adherence Alliance.

  • Internal Medicine Physician, MD from Northeastern Ohio Universities College of Medicine
  • Adjunct Assistant Professor, UNC Chapel Hill, Eshelman School of Pharmacy
  • Fellow, National Library of Medicine, Medical Informatics at UNC/Duke University
  • Fellow, Office of Medical Education Research & Development, Michigan State University